UnitedHealth Group (UNH)
330.48
-19.43 (-5.55%)
NYSE · Last Trade: Nov 20th, 2:13 AM EST
Detailed Quote
| Previous Close | 349.91 |
|---|---|
| Open | 351.13 |
| Bid | 328.01 |
| Ask | 329.69 |
| Day's Range | 324.67 - 353.85 |
| 52 Week Range | 255.96 - 461.62 |
| Volume | 19,837,323 |
| Market Cap | 296.11B |
| PE Ratio (TTM) | 18.86 |
| EPS (TTM) | 17.5 |
| Dividend & Yield | 9.280 (2.81%) |
| 1 Month Average Volume | 6,228,763 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
Dow Jones Losers Today: NIKE and UnitedHealth Lead Declineschartmill.com
Via Chartmill · November 19, 2026
S&P 500 Top Movers: Gainers and Losers Todaychartmill.com
Via Chartmill · November 19, 2026
S&P 500 Unusual Volume Movers for Nov. 19, 2026chartmill.com
Via Chartmill · November 19, 2026
Dow Jones Decliners: UNH, NKE, CAT Lead Today's Sessionchartmill.com
Via Chartmill · November 19, 2026
S&P 500 Top Movers for Today's Sessionchartmill.com
Via Chartmill · November 19, 2026
Dow Jones Top Movers: Decliners Lead Nov. 18, 2026 Sessionchartmill.com
Via Chartmill · November 18, 2026
S&P 500 Unusual Volume Movers: Nov. 18, 2026chartmill.com
Via Chartmill · November 18, 2026
Dow Jones Losers: Salesforce Leads Today's Steepest Declineschartmill.com
Via Chartmill · November 17, 2026
Dow Jones Losers in Today's US Sessionchartmill.com
Via Chartmill · November 17, 2026
Wall Street's troubles are mounting as expectations for further interest rate hikes overshadow strong corporate earnings and threaten to undermine the market's long-term upward trend.
Via The Motley Fool · November 18, 2026
S&P 500 Top Movers: Today's US Session Gainers and Loserschartmill.com
Via Chartmill · November 18, 2026
Another round of impressive corporate earnings is doing little to reverse Wall Street's recent slide, as investors grapple with elevated valuations, mounting interest rate concerns, and growing uncertainty surrounding the AI boom.
Via The Motley Fool · November 18, 2026
S&P 500 Top Movers: Gainers and Losers in the Nov. 18, 2026 US Sessionchartmill.com
Via Chartmill · November 18, 2026
S&P 500 Gap-Down Movers for Nov. 18 Sessionchartmill.com
Via Chartmill · November 18, 2026
Here are conservative, base, and bull scenarios for where the stock could trade by 2031.
Via The Motley Fool · November 18, 2026
UnitedHealth has raised its 2026 outlook three times as its Medicare Advantage and Optum segments recover.
Via The Motley Fool · November 17, 2026
Major indexes fell again as AI fears and technology outages weigh on confidence, and Nvidia's after-the-bell earnings beat expectations, today, Nov. 17, 2026.
Via The Motley Fool · November 17, 2026
S&P 500 Losers: Software Stocks Lead Session Declineschartmill.com
Via Chartmill · November 17, 2026
S&P 500 Premarket Movers on Nov. 17: Gainers and Loserschartmill.com
Via Chartmill · November 17, 2026
Elevance Health (NYSE:ELV) expects adjusted earnings per share to grow at least 12% in 2027 from its recently increased 2026 baseline of at least $26.75, Chief Financial Officer Mark Kaye said at a UBS conference.
Kaye said the outlook rests on improving health insurance margins, disciplined pricin
Via MarketBeat · November 13, 2026
They've headed in different directions this year, but both are long-term no-brainers.
Via The Motley Fool · November 12, 2026
AbbVie, Merck and Gilead Sciences offer growing dividends alongside pipeline-driven growth, making pharmaceutical stocks a defensive option as investors seek shelter from market volatility.
Via MarketBeat · November 12, 2026
Management has done a solid job correcting the miscalculations of 2025.
Via The Motley Fool · November 12, 2026
The health insurer's turnaround is lifting earnings. Here's what annual growth between 13% and 16% could mean for its stock by 2029.
Via The Motley Fool · November 11, 2026
Madeline S. Bell, former president and CEO of Children’s Hospital of Philadelphia (CHOP), is joining UnitedHealth Group’s (NYSE: UNH) Board of Directors, effective immediately.
By UnitedHealth Group · Via Business Wire · November 9, 2026
